Leios Therapeutics, an innovative aesthetic therapies company, announced on August 31, 2026 that it has...
China Medical System Holdings Limited (CMS) (HKG: 0867) announced that its Southeast Asia subsidiary, Rxilient...
China Medical System Holdings Limited (CMS) (HKG: 0867) announced today that the National Medical Products...
InSilico Medicine (HKG: 3696) announced an additional strategic collaboration with China Medical System Holdings Limited...
China Medical System Holdings Limited (HKG: 0867) announced that the National Medical Products Administration (NMPA)...
China Medical System Holdings Limited (CMS, HKG: 0867) announced it has received clinical trial authorization...
China Medical System Holdings Limited (CMS, HKG: 0867) announced an exclusive licensing agreement with Denmark-based...
China Medical System Holdings Limited (CMS; HKG: 0867) announced that the National Medical Products Administration...
China Medical System Holdings (CMS; HKG: 0867) announced marketing approval from China’s National Medical Products...
China Medical System Holdings (CMS; HKG: 0867) announced that first prescriptions of Ruxolitinib Phosphate Cream...
China Medical System Holdings Limited (CMS, HKG: 0867) announced clinical study approval from China’s National Medical...
China Medical System Holdings Limited (HKG: 0867) announced a licensing agreement with Teikoku Seiyaku Co., Ltd.,...
China Medical System Holdings Limited (HKG: 0867) announced that the National Medical Products Administration (NMPA) has...
China Medical System Holdings (CMS; HKG: 0867) announced that the National Medical Products Administration (NMPA) has...
China Medical System Holdings (CMS; HKG: 0867) announced that the National Medical Products Administration (NMPA) has...
Viva Biotech (HKG: 1873) and China Medical System Holdings Limited (CMS; HKG: 0867, SGX: 8A8)...
Novartis (NYSE: NVS) announced on October 27, 2025, the signing of a strategic cooperation agreement...
On September 12, 2025, Jingze Biopharmaceutical (Hefei) Co., Ltd., based in China, and a subsidiary...
China‑based AccurEdit Therapeutics (Suzhou) Co., Ltd. announced that it has closed a US$75 million Series A financing...
China Medical System Holdings Limited (CMS, HKG: 0867) announced that the National Medical Products Administration...